# Cannabis and Driving? Studies Reveal Big Risks > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-impaired-driving-risks/ > **Published:** 2026-04-21T05:04:28-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:16:21-04:00 > **Clinical Summary:** Explore cannabis-impaired driving risks and clinical guidance on impairment duration and safety for patients and public health. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic ImpairmentSafety[Public Health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/)Patient EducationThc Why This Matters Cannabis-impaired driving presents a growing clinical and public safety concern as legalization expands. Clinicians need evidence-based guidance to counsel patients about impairment risks and timing of [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) relative to driving, especially given the complex pharmacokinetics of different cannabis products. Clinical Summary Research demonstrates measurable driving impairment with [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), though the relationship between THC blood levels and functional impairment remains complex and less predictable than alcohol. Impairment duration varies significantly by consumption method — smoking/vaping may impair for 3-4 hours while edibles can affect driving ability for 6-8 hours or longer. Individual factors including tolerance, product potency, and co-use with other substances further complicate impairment assessment. Dr. Caplan’s Take “I tell patients that cannabis affects reaction time and decision-making in ways that compromise driving safety, period. Unlike alcohol, we don’t have reliable biomarkers to predict when someone is too impaired to drive — so the safest approach is planning alternative transportation whenever cannabis is involved.” Clinical Perspective 🧠 Clinicians should provide specific guidance about timing between cannabis use and driving, emphasizing that impairment outlasts subjective intoxication. Patients using cannabis medically need clear protocols for maintaining medication adherence while avoiding impaired driving. Document these safety discussions as legal cannabis markets create new liability considerations for prescribing clinicians. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabis%20and%20Driving%3F%20Studies%20Reveal%20Big%20Risks%20%40drcaplan&url=https%3A//news.cuanschutz.edu/news-stories/cannabis-and-driving-studies-reveal-big-risks)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//news.cuanschutz.edu/news-stories/cannabis-and-driving-studies-reveal-big-risks)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabis%20and%20Driving%3F%20Studies%20Reveal%20Big%20Risks%20--%20via%20%40drcaplan.bsky.social%20https%3A//news.cuanschutz.edu/news-stories/cannabis-and-driving-studies-reveal-big-risks)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://news.cuanschutz.edu/news-stories/cannabis-and-driving-studies-reveal-big-risks](https://news.cuanschutz.edu/news-stories/cannabis-and-driving-studies-reveal-big-risks) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this cannabis news?](#What_is_the_clinical_relevance_rating_for_this_cannabis_news) - [What are the main safety concerns addressed in this cannabis-related update?](#What_are_the_main_safety_concerns_addressed_in_this_cannabis-related_update) - [Why is this information important for patient education?](#Why_is_this_information_important_for_patient_education) - [How does this relate to public health policy?](#How_does_this_relate_to_public_health_policy) - [What should healthcare providers take away from this update?](#What_should_healthcare_providers_take_away_from_this_update) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare professionals should monitor closely. #### What are the main safety concerns addressed in this cannabis-related update? The article focuses on impairment and safety issues related to cannabis use. These are critical considerations for both [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) patients and [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) policy development. #### Why is this information important for patient education? Healthcare providers need current information about cannabis impairment and safety to properly educate patients about potential risks. This helps ensure patients can make informed decisions about their treatment options. #### How does this relate to public health policy? The findings contribute to the broader understanding of [cannabis safety](https://cedclinic.com/respiratory-effects-inhalational-marijuana/) profiles that inform public health guidelines. This information helps shape evidence-based policies around cannabis use and regulation. #### What should healthcare providers take away from this update? Clinicians should stay informed about emerging [cannabis safety](https://cedclinic.com/respiratory-effects-inhalational-marijuana/) data to provide accurate patient counseling. The “Notable Clinical Interest” rating indicates this information warrants attention in clinical practice discussions. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis vs Alcohol: Different Effects on Driving](https://cedclinic.com/cannabis-alcohol-affect-driving-differently/) Learn how cannabis and alcohol differently affect driving abilities and impairment risks. [Read More](https://cedclinic.com/cannabis-alcohol-affect-driving-differently/) [Virginia Launches Campaign Against Cannabis-Impaired Driving](https://cedclinic.com/cannabis-impaired-driving-risks-safety-campaign-virginia/) Discover public health efforts to reduce driving after cannabis use in Virginia. [Learn More](https://cedclinic.com/cannabis-impaired-driving-risks-safety-campaign-virginia/) [Medical Marijuana & Driving Performance](https://cedclinic.com/medical-marijuana-driving-performance/) Explore how [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) affects driving performance and safety considerations. [Explore Now](https://cedclinic.com/medical-marijuana-driving-performance/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).